Patents by Inventor Takuya Tashiro
Takuya Tashiro has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230306944Abstract: A method of outputting a parameter of a sound processing device receives an audio signal, obtains information of the parameter of the sound processing device, which corresponds to the received audio signal, by using a trained model obtained by performing training of a relationship among a training output sound of the sound processing device, a training input sound of the sound processing device, and a parameter of sound processing performed by the sound processing device, the parameter of the sound processing device being receivable by a user of the sound processing device, and outputs obtained information of the parameter of the sound processing device corresponding to the received audio signal.Type: ApplicationFiled: March 21, 2023Publication date: September 28, 2023Inventors: Yu TAKAHASHI, Hayato YAMAKAWA, Yoshifumi MIZUNO, Takuya SHIBATA, Tatsuki TASHIRO, Ryohei TAKEUCHI, Yuki SAKAMOTO, Jinichi KONNO, Yusuke OTA
-
Publication number: 20230246274Abstract: Power source device includes: battery stack in which a plurality of battery cells are stacked; a pair of end plates that each have a plate shape having a main surface and a side surface intersecting the main surface, are formed with plate screw hole on the side surface, and are arranged on both side end surfaces of battery stack; a plurality of fastening members that are extended in stack direction of the battery stack, have fastening screw holes opened at ends, and couple end plates to each other; and bolt that is inserted into fastening screw hole of each fastening member and plate screw hole of end plate to fix the fastening member to end plate. The fastening member includes plate-shaped fastening body, intermediate part obtained by bending both ends of fastening body, and coupling piece obtained by bending an end of intermediate part far from fastening body to provide a height difference from fastening body and form fastening screw hole.Type: ApplicationFiled: January 20, 2021Publication date: August 3, 2023Inventors: YUSUKE FUJII, YOSHIMITSU TASHIRO, TAKUYA EGASHIRA
-
Publication number: 20230178844Abstract: Power supply device (100) includes: battery stack (10) in which a plurality of battery cells (1) are stacked, each battery cell (1) having gas discharge valve (1c) that opens when an internal pressure of an outer covering can rises and electrode terminal (2) formed on an upper surface; first cover (41) that is provided on an upper surface of battery stack (10) and opens at a position corresponding to gas discharge valve (1c); and second cover (42) that is provided on an upper surface of first cover (41) and defines gas duct (38) with first cover (41). Gas duct (38) forms baffle plate (48) between first cover (41) and second cover (42). Power supply device (100) further includes metallic third cover (39) provided on an upper surface of second cover (42) and abutting on the upper surface of second cover (42).Type: ApplicationFiled: January 20, 2021Publication date: June 8, 2023Inventors: YUSUKE FUJII, YOSHIMITSU TASHIRO, TAKUYA EGASHIRA
-
Patent number: 11052630Abstract: A sheet processor subjecting a sheet having been conveyed forward to processing along a direction perpendicular to a conveyance direction of the sheet, includes: a processing unit performing the processing; and a receiving unit receiving the processing unit therein in a state capable of perfecting the processing on the sheet, and the processing unit includes a first processing tool 4A and a second processing tool 4B disposed to vertically oppose each other with a conveyance surface of the sheet disposed therebetween, and the receiving unit includes at least one receiver that removably receives the first processing tool 4A and the second processing tool 4B in the state capable of performing the processing on the sheet, with arbitrarily selected one of the first processing tool 4A and the second processing tool 4B disposed above the conveyance surface, and with arbitrarily selected another of the first processing tool 4A and the second processing tool 4B disposed below the conveyance surface.Type: GrantFiled: May 22, 2018Date of Patent: July 6, 2021Assignee: DUPLO SEIKO CORPORATIONInventors: Hideki Oiwa, Yasuhiro Tanaka, Masayasu Matsumoto, Takuya Tashiro
-
Publication number: 20180339483Abstract: A sheet processor subjecting a sheet having been conveyed forward to processing along a direction perpendicular to a conveyance direction of the sheet, includes: a processing unit performing the processing; and a receiving unit receiving the processing unit therein in a state capable of perfecting the processing on the sheet, and the processing unit includes a first processing tool 4A and a second processing tool 4B disposed to vertically oppose each other with a conveyance surface of the sheet disposed therebetween, and the receiving unit includes at least one receiver that removably receives the first processing tool 4A and the second processing tool 4B in the state capable of performing the processing on the sheet, with arbitrarily selected one of the first processing tool 4A and the second processing tool 4B disposed above the conveyance surface, and with arbitrarily selected another of the first processing tool 4A and the second processing tool 4B disposed below the conveyance surface.Type: ApplicationFiled: May 22, 2018Publication date: November 29, 2018Applicant: DUPLO SEIKO CORPORATIONInventors: Hideki OIWA, Yasuhiro TANAKA, Masayasu MATSUMOTO, Takuya TASHIRO
-
Patent number: 9493497Abstract: The invention provides a compound effective as an antitumor active agent or vaccine adjuvant and an intermediate useful for the synthesis of the compound, as well as production methods thereof, and a medicament containing the novel compound. The compound is a carbamate glycolipid represented by the formula (I) wherein each symbol is as defined herein. The invention also provides a dendritic cell pulsed with the glycolipid.Type: GrantFiled: April 26, 2013Date of Patent: November 15, 2016Assignee: RIKENInventors: Takuya Tashiro, Kenji Mori, Masao Shiozaki, Masaru Taniguchi, Hiroshi Watarai
-
Patent number: 9464105Abstract: The invention provides a compound represented by the formula (I) wherein R1 is a hydrogen atom or a hydroxyl group; two R2 are the same or different and each is a hydrogen atom or a hydroxyl group; R3 is a hydrocarbon group having 8-14 carbon atoms, which optionally has substituent(s); and R4 is a hydrocarbon group having 18-24 carbon atoms, which optionally has substituent(s), or a salt thereof. The invention also provides a method of treating an autoimmune disease or suppressing immunity by administering the aforementioned compound or a salt thereof to a patient in need thereof.Type: GrantFiled: August 2, 2013Date of Patent: October 11, 2016Assignee: RIKENInventors: Masao Shiozaki, Takuya Tashiro, Kenji Mori, Tomokuni Shigeura, Hiroshi Watarai, Masaru Taniguchi
-
Publication number: 20150218199Abstract: The invention provides a compound represented by the formula (I) wherein R1 is a hydrogen atom or a hydroxyl group; two R2 are the same or different and each is a hydrogen atom or a hydroxyl group; R3 is a hydrocarbon group having 8-14 carbon atoms, which optionally has substituent(s); and R4 is a hydrocarbon group having 18-24 carbon atoms, which optionally has substituent(s), or a salt thereof. The invention also provides a method of treating an autoimmune disease or suppressing immunity by administering the aforementioned compound or a salt thereof to a patient in need thereof.Type: ApplicationFiled: August 2, 2013Publication date: August 6, 2015Inventors: Masao Shiozaki, Takuya Tashiro, Kenji Mori, Tomokuni Shigeura, Hiroshi Watarai, Masaru Taniguchi
-
Publication number: 20150152128Abstract: The invention provides a compound effective as an antitumor active agent or vaccine adjuvant and an intermediate useful for the synthesis of the compound, as well as production methods thereof, and a medicament containing the novel compound. The compound is a carbamate glycolipid represented by the formula (I) wherein each symbol is as defined herein. The invention also provides a dendritic cell pulsed with the glycolipid.Type: ApplicationFiled: April 26, 2013Publication date: June 4, 2015Inventors: Takuya Tashiro, Kenji Mori, Masao Shiozaki, Masaru Taniguchi., Hiroshi Watarai
-
Patent number: 8853173Abstract: A compound represented by the following formula (1): wherein R1 is an aldopyranose residue wherein the 6-hydroxyl group is optionally alkylated, R2 is a C1-26 hydrocarbon group optionally having substituent(s), R3 is a hydrogen atom or a C1-26 hydrocarbon group optionally having substituent(s), R4 is a C1-21 hydrocarbon group optionally having substituent(s), X is an oxygen atom or —CH2—, and Y is —CH2—, —CH(OH)— or —CH?CH—, or a salt thereof is useful for the prophylaxis or treatment of cancer or infection, since it can preferentially induce production of IFN-? of NKT cells.Type: GrantFiled: February 4, 2011Date of Patent: October 7, 2014Assignee: RIKENInventors: Takuya Tashiro, Kenji Mori, Masao Shiozaki, Masaru Taniguchi, Hiroshi Watarai
-
Patent number: 8580751Abstract: The invention provides esterified ?-galactosylceramides effective for cancer treatment and the like, and a medicament containing same. In particular, the invention relates to a compound represented by the formula (I): wherein R1 is a hydrocarbon group having a carbon number of 1 to 30, R2 is a hydrocarbon group having a carbon number of 1 to 20, R3 is a hydrogen atom or hydrocarbon group having a carbon number of 1 to 5, R4 and R5 are the same or different and each is a hydrogen atom or a hydrocarbon group having a carbon number of 1 to 5, or R4 and R5 in combination form a divalent hydrocarbon group having a carbon number of 1 to 5, and optionally form a ring structure together with the adjacent ethylenedioxy, or a salt thereof.Type: GrantFiled: September 11, 2009Date of Patent: November 12, 2013Assignee: RikenInventors: Masao Shiozaki, Takuya Tashiro, Kenji Mori, Ryusuke Nakagawa, Hiroshi Watarai, Masaru Taniguchi
-
Patent number: 8551959Abstract: The invention provides a glycolipid effective for cancer treatment and the like and a synthetic intermediate therefor, as well as a medicament containing the glycolipid and the like.Type: GrantFiled: March 25, 2009Date of Patent: October 8, 2013Assignee: RIKENInventors: Takuya Tashiro, Kenji Mori, Masao Shiozaki, Ryusuke Nakagawa, Masaru Taniguchi, Hiroshi Watarai
-
Publication number: 20130005669Abstract: A compound represented by the following formula (1): wherein R1 is an aldopyranose residue wherein the 6-hydroxyl group is optionally alkylated, R2 is a C1-26 hydrocarbon group optionally having substituent(s), R3 is a hydrogen atom or a C1-26 hydrocarbon group optionally having substituent(s), R4 is a C1-21 hydrocarbon group optionally having substituent(s), X is an oxygen atom or —CH2—, and Y is —CH2—, —CH(OH)— or —CH?CH—, or a salt thereof is useful for the prophylaxis or treatment of cancer or infection, since it can preferentially induce production of IFN-? of NKT cells.Type: ApplicationFiled: February 4, 2011Publication date: January 3, 2013Applicant: RIKENInventors: Takuya Tashiro, Kenji Mori, Masao Shiozaki, Masaru Taniguchi, Hiroshi Watarai
-
Patent number: 8299223Abstract: The invention provides a pseudoglycolipid effective for cancer treatment and the like and a novel synthesis intermediate therefor, as well as a medicament containing the pseudoglycolipid and the like. The inventive compound is represented by the formula (1), or a salt thereof, wherein each symbol is as defined in the specification.Type: GrantFiled: February 22, 2008Date of Patent: October 30, 2012Assignee: RikenInventors: Takuya Tashiro, Kenji Mori, Ken-ichi Fuhshuku, Masaru Taniguchi, Ryusuke Nakagawa, Hiroshi Watarai
-
Patent number: 8173608Abstract: The present invention relates to a compound represented by the following formula (1?) wherein R is an aldopyranose residue, R2 is a C2-18 hydrocarbon group optionally having substituent(s), R3 is an acyl group, X is an oxygen atom, a sulfur atom or —NH—, and p is an integer of 0-4, or a salt thereof. The compound of the present invention has a specific immunoregulatory ability, and is useful for the prophylaxis or treatment of autoimmune diseases and the like.Type: GrantFiled: March 3, 2006Date of Patent: May 8, 2012Assignee: RikenInventors: Ken-ichi Fuhshuku, Kenji Mori, Takuya Tashiro, Masaru Taniguchi, Ken-ichiro Seino
-
Patent number: 8163705Abstract: The present invention provide a compound represented by the following formula (1) wherein each symbol is as defined in the specification, or a salt thereof. The compound of the present invention and a salt thereof can preferentially induce production of IL-4, which is one kind of cytokines that control action of immunocytes. Therefore, it is useful for the prophylaxis or treatment of autoimmune diseases, infectious diseases and the like, and prophylaxis or treatment of diseases caused by functional promotion of Th1 cells.Type: GrantFiled: February 28, 2007Date of Patent: April 24, 2012Assignee: RikenInventors: Takuya Tashiro, Kenji Mori, Ken-ichi Fuhshuku, Masaru Taniguchi, Kenichiro Seino
-
Publication number: 20110224158Abstract: The invention provides esterified ?-galactosylceramides effective for cancer treatment and the like, and a medicament containing same. In particular, the invention relates to a compound represented by the formula (I): wherein R1 is a hydrocarbon group having a carbon number of 1 to 30, R2 is a hydrocarbon group having a carbon number of 1 to 20, R3 is a hydrogen atom or hydrocarbon group having a carbon number of 1 to 5, R4 and R5 are the same or different and each is a hydrogen atom or a hydrocarbon group having a carbon number of 1 to 5, or R4 and R5 in combination form a divalent hydrocarbon group having a carbon number of 1 to 5, and optionally form a ring structure together with the adjacent ethylenedioxy, or a salt thereof.Type: ApplicationFiled: September 11, 2009Publication date: September 15, 2011Applicant: RIKENInventors: Masao Shiozaki, Takuya Tashiro, Kenji Mori, Ryusuke Nakagawa, Hiroshi Watarai, Masaru Taniguchi
-
Publication number: 20110104188Abstract: The invention provides a glycolipid effective for cancer treatment and the like and a synthetic intermediate therefor, as well as a medicament containing the glycolipid and the like.Type: ApplicationFiled: March 25, 2009Publication date: May 5, 2011Applicant: RIKENInventors: Takuya Tashiro, Kenji Mori, Masao Shiozaki, Ryusuke Nakagawa, Masaru Taniguchi, Hiroshi Watarai
-
Publication number: 20100062990Abstract: The invention provides a pseudoglycolipid effective for cancer treatment and the like and a novel synthesis intermediate therefor, as well as a medicament containing the pseudoglycolipid and the like. The inventive compound is represented by the formula (1), or a salt thereof, wherein each symbol is as defined in the specification.Type: ApplicationFiled: February 22, 2008Publication date: March 11, 2010Applicant: RIKENInventors: Takuya Tashiro, Kenji Mori, Ken-ichi Fuhshuku, Masaru Taniguchi, Ryusuke Nakagawa, Hiroshi Watarai
-
Publication number: 20090221516Abstract: The present invention provide a compound represented by the following formula (1) wherein each symbol is as defined in the specification, or a salt thereof. The compound of the present invention and a salt thereof can preferentially induce production of IL-4, which is one kind of cytokines that control action of immunocytes. Therefore, it is useful for the prophylaxis or treatment of autoimmune diseases, infectious diseases and the like, and prophylaxis or treatment of diseases caused by functional promotion of Th1 cells.Type: ApplicationFiled: February 28, 2007Publication date: September 3, 2009Applicant: RIKENInventors: Takuya Tashiro, Kenji Mori, Ken-ichi Fuhshuku, Masaru Taniguchi, Kenichiro Seino